文献速递泌尿男性生殖肿瘤

根治性前列腺切除术后辅助放疗与早期挽救性放疗对pN1前列腺癌死亡风险的影响

Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death.
PubMed 文献 · J Clin Oncol · 2022-03-15

该研究基于986例死亡(5.50%)的队列,中位随访7.02年,评估pN1前列腺癌根治性前列腺切除术后辅助放疗对比早期挽救性放疗与全因死亡风险的关系。调整后每增加一个阳性盆腔淋巴结,辅助放疗较早期挽救性放疗的全因死亡风险比显著降低(调整HR 0.92,95%CI 0.85-0.99,P=0.03)。在≥4个阳性淋巴结者中,7年调整全因死亡率辅助放疗组7.74% vs 早期挽救性放疗组23.36%,差异15.62%(95%CI 5.90-25.35)未跨0;1-3个阳性淋巴结者无显著差异(14.27% vs 13.89%,差异0.38%,95%CI -7.02至7.79)。

要点

  • pN1前列腺癌术后辅助放疗较早期挽救性放疗与全因死亡风险降低相关(调整HR 0.92,95%CI 0.85-0.99,P=0.03)。
  • ≥4个阳性盆腔淋巴结者7年调整全因死亡率:辅助放疗组7.74% vs 早期挽救性放疗组23.36%,差异15.62%(95%CI 5.90-25.35)。
  • 1-3个阳性淋巴结者7年调整全因死亡率:辅助放疗组14.27% vs 早期挽救性放疗组13.89%,差异0.38%(95%CI -7.02至7.79),无显著差异。

核心结论

  • pN1前列腺癌根治性前列腺切除术后,辅助放疗对比早期挽救性放疗与全因死亡风险降低相关,且该降低随每个额外阳性盆腔淋巴结而增加。

研究设计与样本

  • 研究采用单变量和多变量Cox回归,评估时间依赖性辅助放疗对比早期挽救性放疗的全因死亡风险比是否随阳性盆腔淋巴结数量增加而显著降低。
  • 按1-3个或≥4个阳性盆腔淋巴结分层,计算接受辅助放疗、早期挽救性放疗或无放疗者的调整全因死亡率估计值。

主要发现

  • 中位随访7.02年,986例(5.50%)死亡,其中223例(22.62%)死于前列腺癌。
  • 每增加一个阳性盆腔淋巴结,辅助放疗对比早期挽救性放疗的调整全因死亡风险比为0.92(95%CI 0.85-0.99,P=0.03)。
  • ≥4个阳性淋巴结者7年调整全因死亡率:辅助放疗组7.74% vs 早期挽救性放疗组23.36%,差异15.62%(95%CI 5.90-25.35)。
  • 1-3个阳性淋巴结者7年调整全因死亡率:辅助放疗组14.27% vs 早期挽救性放疗组13.89%,差异0.38%(95%CI -7.02至7.79)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: An association with a reduction in the risk of all-cause mortality (ACM) and the use of adjuvant as compared with early postradical prostatectomy salvage radiation therapy (sRT) in men with pN1 prostate cancer (PC) has been observed. Yet, whether this finding applies irrespective of the number of positive lymph nodes (LNs) after adjusting for the time-dependent use and duration of androgen deprivation therapy is unknown and is addressed in the current study. METHODS: Univariable and multivariable Cox regression was used to evaluate whether the ACM risk ratio for time-dependent use of adjuvant versus early sRT per unit increase in positive pelvic LNs was significantly reduced. Adjusted ACM estimates were calculated among men who received adjuvant, early salvage, or no RT stratified by one to three or four or more positive pelvic LNs. RESULTS: After a median follow-up of 7.02 years, 986 (5.50%) men died, with 223 (22.62%) of PC. Adjuvant compared with early sRT was associated with a significantly lower ACM risk per unit increase in positive pelvic LNs (adjusted hazard ratio: 0.92; 95% CI, 0.85 to 0.99; P = .03). A significant difference in the 7-year adjusted ACM estimates favoring aRT versus early sRT was observed in men with four or more positive LNs (7.74% v 23.36%) in that the 95% CI for the 15.62% difference (5.90 to 25.35) excluded 0.00, but this was not true for men with 1-3 positive LNs (14.27% v 13.89%; 95% CI for the 0.38% difference [-7.02 to 7.79]). CONCLUSION: Adjuvant compared with early sRT in men with pN1 PC was associated with a decreased ACM risk, and this reduction increased with each additional positive pelvic LN.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Tilki D, Chen MH, Wu J, et al. Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death. J Clin Oncol. 2022. PMID: 35290082. doi:10.1200/JCO.21.02800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。